| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 33 |
| 1 | LEVOTHYROXINE SODIUM | 32 |
| 2 | ALEMTUZUMAB | 20 |
| 3 | IPILIMUMAB | 19 |
| 4 | PREGABALIN | 17 |
| 5 | METHYLPREDNISOLONE | 16 |
| 6 | LEVOTHYROXINE SODIUM ANHYDROUS | 15 |
| 7 | PEMBROLIZUMAB | 15 |
| 8 | DIMENHYDRINATE | 12 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 1 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 2 | METHENAMINE HIPPURATE | 2 | 0.0016 |
| 3 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 4 | PIROXICAM | 8 | 0.0012 |
| 5 | ALBUMIN HUMAN | 6 | 0.0012 |
| 6 | DIMENHYDRINATE | 12 | 0.0011 |
| 7 | ALBUMIN (HUMAN) | 6 | 0.0011 |
| 8 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 9 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 20 | 0.0010 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Antifibrinolytic Agent [EPC] | 9 | 0.0009 |
| 3 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 4 | 0.0007 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 50 | 0.0005 |
| 5 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 19 | 0.0004 |
| 7 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 8 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |